Derek J. Jonker

13.8k citations
222 papers · 9.1k · 4 hit papers · h-index 35

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 104
    • Cancer Treatment and Pharmacology 35
    • Cancer Immunotherapy and Biomarkers 20
    • Pancreatic and Hepatic Oncology Research 17
    • Lung Cancer Treatments and Mutations 33
    • Gastric Cancer Management and Outcomes 25

Derek J. Jonker

210 papers receiving 8.9k citations

Derek J. Jonker's Hit Papers

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial 2013 · 445 citations
4450+6+12Years since publication50010001.5k2.0k2.5k

Peers

Derek J. Jonker
Comparison fields: 5 of 121
  • Oncology 5.8k
  • Hepatology 788
  • Cancer Research 1.4k
  • Pathology and Forensic Medicine 1.5k
  • Pulmonary and Respiratory Medicine 1.8k
Replace Chiara Cremolini with:
Chiara Cremolini Italy
Tae Won Kim South Korea
Andrea Sartore‐Bianchi Italy
Joan Maurel Spain
Allen Lee Cohn United States
J. Randolph Hecht United States
Miriam Koopman Netherlands
Robert R. McWilliams United States
Jean‐Luc Van Laethem Belgium
Thomas H. Cartwright United States
Derek J. Jonker relative to Chiara Cremolini Italy Chiara Cremolini's profile →
Citations per field
00.5×1.5×
Chiara Cremolini · 1×
Citations per year

Countries citing papers authored by Derek J. Jonker

Since Specialization
Citations

This map shows the geographic impact of Derek J. Jonker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek J. Jonker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek J. Jonker more than expected).

Fields of papers citing papers by Derek J. Jonker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek J. Jonker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek J. Jonker. The network helps show where Derek J. Jonker may publish in the future.

Co-authors

The 25 scholars most cited alongside Derek J. Jonker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Derek J. Jonker Line = papers co-authored together Derek J. Jonker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.

#Work
1
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Hit paper breakdown →
20082775
2
Cetuximab for the Treatment of Colorectal Cancer
Hit paper breakdown →
20071420
3
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Hit paper breakdown →
2010575
4
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
Hit paper breakdown →
2013445
5 2020276
6 2015255
7 2013131
8 2009122
9 2014112
10 2013111
11 201199
12 200594
13 200988
14
The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.
201186
15 201782
16 200075
17 201365
18 201061
19 201754
20 201153

About Derek J. Jonker

Derek J. Jonker is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 222 papers that have together received 9.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (104 papers), Cancer Treatment and Pharmacology (35 papers), Lung Cancer Treatments and Mutations (33 papers), Gastric Cancer Management and Outcomes (25 papers), Cancer Genomics and Diagnostics (24 papers), Cancer Immunotherapy and Biomarkers (20 papers), Pancreatic and Hepatic Oncology Research (17 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). The work is most often cited by research in Oncology (5.8k citations), Hepatology (788 citations), Cancer Research (1.4k citations), Pathology and Forensic Medicine (1.5k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Derek J. Jonker has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Dongsheng Tu, Christos S. Karapetis, Chris J. O’Callaghan, John Zalcberg, Malcolm J. Moore, Niall C. Tebbutt, Timothy Price, Christiane Langer, R. J. Simes and Shirin Khambata‐Ford. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, Clinical Cancer Research and Clinical Colorectal Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact